Automate Your Wheel Strategy on CVS
With Tiblio's Option Bot, you can configure your own wheel strategy including CVS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CVS
- Rev/Share 300.5234
- Book/Share 61.1499
- PB 1.0533
- Debt/Equity 1.0557
- CurrentRatio 0.8227
- ROIC 0.0403
- MktCap 81290185200.0
- FreeCF/Share 4.7113
- PFCF 13.6829
- PE 15.3469
- Debt/Assets 0.3178
- DivYield 0.0414
- ROE 0.0698
- Rating A-
- Score 4
- Recommendation Buy
- P/E Score 2
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | CVS | Leerink Partners | Market Perform | Outperform | $55 | $75 | Feb. 13, 2025 |
| Upgrade | CVS | Cantor Fitzgerald | Neutral | Overweight | -- | -- | Feb. 12, 2025 |
| Upgrade | CVS | Edward Jones | Hold | Buy | -- | -- | Jan. 30, 2025 |
| Upgrade | CVS | Deutsche Bank | Hold | Buy | -- | $66 | Dec. 3, 2024 |
| Upgrade | CVS | Barclays | Equal Weight | Overweight | $63 | $82 | Oct. 10, 2024 |
| Upgrade | CVS | TD Cowen | Hold | Buy | $59 | $85 | Oct. 4, 2024 |
News
The 3 Best Performing S&P 500 Stocks of 2025 Q1
Published: March 31, 2025 by: Zacks Investment Research
Sentiment: Neutral
We're nearing the end of the calendar-year Q1, with many S&P 500 stocks delivering strong performances year-to-date despite recent volatility stemming from tariff talks and other economic developments.
Read More
Stocks: Best and worst performers of Q1
Published: March 31, 2025 by: Yahoo Finance
Sentiment: Neutral
On the final day of the first quarter of 2025, Madison Mills and Julie Hyman take a look at the best and worst-performing stocks and sectors of the year so far. Among the worst performers are Deckers (DECK) and Tesla (TSLA), while CVS Health (CVS) led gains.
Read More
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
Published: March 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
3 Stocks to Buy As Tariff Turmoil Unfolds
Published: March 27, 2025 by: 24/7 Wall Street
Sentiment: Neutral
Tariff turmoil has continued to provide intense volatility for the stock market, with certain sector seeing outsized losses as investors price in the risk of tariffs being put in place on a number of sectors and countries which export products to the U.S.
Read More
Why the Market Dipped But CVS Health (CVS) Gained Today
Published: March 26, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) closed at $67.20 in the latest trading session, marking a +1.08% move from the prior day.
Read More
Compelling Weight Management Program Data Set to Boost CVS Stock
Published: March 17, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health shares impressive findings from its Weight Management Program.
Read More
CVS Stock Soars 47% YTD: Is Digital Growth Fueling a Buy Opportunity?
Published: March 11, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health is consistently increasing investments in fast-growing spaces like enterprise data platforms, cloud capabilities and digital products.
Read More
CVS opens smaller format stores as industry sees big shift
Published: March 11, 2025 by: Fox Business
Sentiment: Neutral
CVS is opening new stores around the nation, but they will be significantly smaller and focus only on pharmacy services. The move comes as the industry undergoes a major shift.
Read More
CVS is opening smaller drugstores that only have pharmacies
Published: March 10, 2025 by: New York Post
Sentiment: Positive
CVS said it will open a dozen or more drugstores that only have pharmacies as it scrambles to remain competitive against rivals like Target, Amazon, Walgreens, and Rite Aid. The smaller stores, each location averaging less than 5,000 square feet, will feature a full service pharmacy with limited over-the-counter products for purchase.
Read More
Wellvana acquires CVS Health's MSSP business
Published: March 04, 2025 by: PRNewsWire
Sentiment: Neutral
With latest transaction, Wellvana supports primary care providers across 40 states, serving approximately 1 million patients. NASHVILLE, Tenn.
Read More
Thermo Fisher Scientific Elects New Director to Board
Published: February 19, 2025 by: Business Wire
Sentiment: Neutral
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced Karen S. Lynch has been elected to its board of directors, effective February 19, 2025. The appointment brings the total number of Thermo Fisher board members to 12. Ms. Lynch is a seasoned health care executive with over three decades of experience in the industry. As the former president and chief executive officer of CVS Health Corporation (NYSE: CVS), a leading hea.
Read More
These Were the 5 Top-Performing Stocks in the S&P 500 in January 2025
Published: February 19, 2025 by: The Motley Fool
Sentiment: Positive
Extending its 23%-plus climb during 2024, the S&P 500 started 2025 off with a bang, rising 2.7% in January.
Read More
This stock is up 50% already since Jim Cramer's warning
Published: February 19, 2025 by: Finbold
Sentiment: Neutral
Jim Cramer, the eccentric host of ‘Mad Money' on CNBC, is one of the most recognizable voices covering finance in the United States. Recognizable, however, does not necessarily equate to reverence.
Read More
Top 2 cheap stocks to buy for 2025
Published: February 18, 2025 by: Invezz
Sentiment: Positive
The US consumer price index (CPI) was up more than expected in January, raising doubts about the Federal Reserve's ability to lower interest rates further in 2025.
Read More
CVS Health: One Good Quarter Is Not Enough; Retain Sell
Published: February 18, 2025 by: Seeking Alpha
Sentiment: Negative
Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage levels. CVS' Q4 results showed a surprising EBIT margin beat, but continued margin erosion in its insurance business remains a concern. Improved margin performance in FY25 is possible with better insurance policy terms and reduced loss-making membership counts but given a poor execution record, it is better to wait for evidence.
Read More
Is It Too Late to Buy CVS Health Stock for the High-Yield Dividend?
Published: February 18, 2025 by: The Motley Fool
Sentiment: Negative
After underperforming throughout 2024, shares of CVS Health (CVS -0.81%) are surging. From the end of 2024 through Feb. 14, the stock climbed 46.7% higher.
Read More
CVS Health Post-Q4 Earnings: Is the Stock Worth Buying Now?
Published: February 17, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health's adjusted EPS outlook for 2025 reflects expectations of a meaningful recovery in Medicare Advantage and continued growth in Health Services.
Read More
Ed DeVaney named President of CVS Caremark
Published: February 17, 2025 by: PRNewsWire
Sentiment: Neutral
WOONSOCKET, R.I. , Feb. 17, 2025 /PRNewswire/ -- Today, CVS Health® (NYSE: CVS) named Ed DeVaney president of the company's CVS Caremark pharmacy benefit management business.
Read More
Why CVS Stock Thrashed the Market on Thursday
Published: February 13, 2025 by: The Motley Fool
Sentiment: Neutral
For the second day in a row, CVS Health's (CVS 4.98%) stock price saw a satisfying jump on Thursday. It closed the day almost 5% higher, on the back of both lingering optimism and news of another in a series of analyst price target raises.
Read More
CVS shares are up 45% this year — here's why it may be starting to turn its business around
Published: February 13, 2025 by: CNBC
Sentiment: Positive
CVS Health could be starting to turn itself around after a dismal 2024. Its shares are up more than 45% this year, outperforming pharmacy rival Walgreens and other insurers like UnitedHealth Group and Cigna.
Read More
CVS Health: Earnings Beat Ignites Stock Rally
Published: February 13, 2025 by: MarketBeat
Sentiment: Neutral
Shares of CVS Health Corporation NYSE: CVS experienced a jolt, rising over 15% on February 12, 2025, as the market responded to the release of its fourth-quarter 2024 earnings report. CVS Health's stock price increase comes after a period of decline, causing investors to question whether this is a temporary upswing or a sign of a genuine turnaround.
Read More
S&P 500 Gains and Losses Today: CVS Stock Jumps as Pharmacy Segment Delivers Growth
Published: February 12, 2025 by: Investopedia
Sentiment: Positive
Major U.S. equities indexes were mixed on Wednesday as the latest Consumer Price Index (CPI) data showed an unexpected uptick in inflation during January.
Read More
Nasdaq Edges Higher; CVS Health Shares Jump Following Upbeat Earnings
Published: February 12, 2025 by: Benzinga
Sentiment: Positive
U.S. stocks traded mostly lower toward the end of trading, while the Nasdaq Composite edged higher on Wednesday.
Read More
CVS CEO defends pharmacy middlemen, accuses drugmakers of 'monopolistic' practices
Published: February 12, 2025 by: CNBC
Sentiment: Negative
CVS Health CEO David Joyner defended controversial pharmacy middlemen, who are widely accused of inflating prescription medication prices, and instead accused manufacturers of "monopolistic" practices that keep drug costs high in the U.S. Joyner, who stepped into the role in October, spent much of his opening remarks on the company's fourth-quarter earnings call discussing so-called pharmacy benefit managers, or PBMs.
Read More
Trade Tracker: Joe Terranova buys CVS and Alibaba
Published: February 12, 2025 by: CNBC Television
Sentiment: Positive
Joe Terranova, Senior Managing Director for Virtus Investment Partners, joins CNBC's "Halftime Report" to explain why he's buying these two stocks at these levels.
Read More
Why CVS Health Stock Popped Today
Published: February 12, 2025 by: The Motley Fool
Sentiment: Positive
Shares of CVS Health (CVS 13.66%) were soaring Wednesday after the diversified healthcare giant's fourth-quarter results topped estimates and management offered better-than-expected guidance for 2025.
Read More
CVS Beats EPS Estimates, Losses Loom
Published: February 12, 2025 by: The Motley Fool
Sentiment: Positive
CVS Health (CVS 13.34%), a leading integrated healthcare and pharmacy solutions provider, released its fourth-quarter 2024 earnings on February 12, 2025.
Read More
CVS Stock Approaches Q4 Earnings With Resistance In Sight
Published: February 11, 2025 by: Benzinga
Sentiment: Neutral
CVS Health Corp CVS will be reporting its fourth-quarter earnings on Wednesday. Wall Street expects 94 cents in EPS and $97.20 billion in revenues as the company reports before market hours.
Read More
What's a Fair Price for CVS Stock?
Published: February 11, 2025 by: The Motley Fool
Sentiment: Neutral
CVS (CVS 1.23%) is struggling to stay relevant amid rising costs and declining customer visits.
Read More
Dividend Roundup: Why CVS Health Is Still Better Than Walgreens
Published: February 10, 2025 by: Seeking Alpha
Sentiment: Negative
Investors drawn to WBA and CVS must feel disappointed. WBA's recent dividend suspension and CVS's dividend freeze reflect financial headwinds and operational challenges. I won't consider either as a buy candidate.
Read More
About CVS Health Corporation (CVS)
- IPO Date 1996-11-20
- Website https://www.cvshealth.com
- Industry Medical - Healthcare Plans
- CEO Mr. J. David Joyner CEBS
- Employees 219000